oxazoles has been researched along with Carcinogenesis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguado, T; Albiñana, V; Botella, LM; Campuzano, S; Cuesta, ÁM; Garcia-Sanz, JA; Granados, R; Pingarrón, JM; Romero-Revilla, JA; Sánchez-Puelles, JM; Sánchez-Sancho, F; Santamaría, S; Torrente-Rodríguez, RM | 1 |
| Afaq, F; Arumugam, A; Athar, M; Chaudhary, SC; Elmets, CA; Kopelovich, L; Singh, T; Srivastava, RK; Talwelkar, SS; Weng, Z | 1 |
| Gonzalez, FJ; Peters, JM; Yao, PL | 1 |
3 other study(ies) available for oxazoles and Carcinogenesis
| Article | Year |
|---|---|
11PS04 is a new chemical entity identified by microRNA-based biosensing with promising therapeutic potential against cancer stem cells.
Topics: Animals; Antineoplastic Agents; Biosensing Techniques; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Gene Expression Regulation, Neoplastic; Glioma; Magnetic Phenomena; Mammary Glands, Animal; Mice; MicroRNAs; Neoplastic Stem Cells; Oxazoles; Reproducibility of Results; Spheroids, Cellular; Temozolomide; Xenograft Model Antitumor Assays | 2019 |
Erb-041, an estrogen receptor-β agonist, inhibits skin photocarcinogenesis in SKH-1 hairless mice by downregulating the WNT signaling pathway.
Topics: Animals; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Estrogen Receptor beta; Female; Humans; Mice; Mice, Hairless; Oxazoles; Skin Neoplasms; Ultraviolet Rays; Wnt Signaling Pathway | 2014 |
Targeting estrogen receptor-β for the prevention of nonmelanoma skin cancer.
Topics: Animals; Carcinogenesis; Female; Humans; Oxazoles; Skin Neoplasms; Wnt Signaling Pathway | 2014 |